Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesEfficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine
Alimentary Pharmacology and Therapeutics, 08/20/09
Bloom SL et al. – Methotrexate appears effective in both CD and UC patients who fail to respond to or are intolerant to AZA/MP therapy.
Related Articles
A Case-Control Study on Risk Factors of Osteoporosis in Patients with Crohn's Disease
Archives of Iranian Medicine, 11/13/09
Relevance Score: 83%
Impact of disease activity on resting energy expenditure in children with inflammatory bowel disease
Clinical Nutrition, 11/18/09
Relevance Score: 82%
Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09
Relevance Score: 82%
Methotrexate for maintenance of remission in Crohn's disease
Cochrane Reviews, 10/27/09
Relevance Score: 82%
Malignant Transformation in Perianal Fistulas of Crohns Disease: a Systematic Review of Literature
Journal of Gastrointestinal Surgery, 10/21/09
Relevance Score: 82%
Today in Inflammatory Bowel Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease
World Journal of Gastroenterology, 12/15/09
Analysis of Court Criteria for Awarding Disability Benefits to Patients With Crohn's Disease
Clinical Gastroenterology and Hepatology , 12/15/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Cost-utility analysis of infliximab and adalimumab for refractory ulcerative colitis
Cost Effectiveness and Resource Allocation, 12/15/09
Medication Usage and the Risk of Neoplasia in Patients With Barretts Esophagus
Clinical Gastroenterology and Hepatology , 12/15/09
Spontaneous bacterial peritonitis: Few additional points
World Journal of Gastroenterology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor